Meet Cyntegrity on French EPharma Day in Paris, which is dedicated to European Regulation and Data Transparency. On Wednesday, 25 November 2015, Cyntegrity will present “How to Master the new EU Regulation with Risk-based Monitoring (RBM)”. The presentation will demonstrate that risk management is much wider concept as only optimization of monitoring activities, the Cynetgrity’s management will show practical case studies how RBM (in its wider meaning) can be a mechanism to master the new EU regulation No 536/2014.
About the Author: Artem Andrianov, Ph.D., MBA
Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.